A Review on Relationship Between Charcot Neuroarthropathy and Diabetic Patients

被引:1
|
作者
Bansod, Himani [1 ]
Wanjari, Anil [2 ]
Dumbhare, Omkar [3 ]
机构
[1] Datta Meghe Inst Higher Educ & Res, Jawaharlal Nehru Med Coll, Med, Wardha, India
[2] Datta Meghe Inst Higher Educ & Res, Jawaharlal Nehru Med Coll, Cardiol, Wardha, India
[3] Datta Meghe Inst Higher Educ & Res, Jawaharlal Nehru Med Coll, Genet, Wardha, India
关键词
diabetes-related foot disorders; musculoskeletal complications; peripheral neuropathy; diabetic patients charcot neuroarthropathy; NECROSIS-FACTOR-ALPHA; RISK-FACTORS; FOOT ULCERS; CLASSIFICATION; MANAGEMENT; INFECTION; DIAGNOSIS; RECEPTOR;
D O I
10.7759/cureus.50988
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Charcot Neuroarthropathy (CN) is a complex and incapacitating disorder characterized by neuropathy, progressive deformity, and joint destruction. It is of substantial interest within the diabetic population as this ailment chiefly affects individuals with diabetes. The pathophysiology of CN is multidimensional, connecting peripheral neuropathy, repetitive trauma, and autonomic dysfunction. The review analyses the mechanisms directing the development of CN, emphasizing the influence of diabetes in individuals who lean toward this condition. Clinical presentation and diagnosis of CN in diabetic patients present unique challenges. Complex clinical features have also been discussed, including joint deformities, insidious onset, and painless swelling, which mimic other musculoskeletal conditions. The diagnostic approaches, involving clinical examination and radiological imaging, are analyzed for early and accurate diagnosis. Risk factors and epidemiology emphasize the prevalence of CN within the diabetic population and draw attention to common risk factors contributing to its development. Significant factors such as glycemic control, duration of the disease, and type of diabetes are important in estimating an individual's risk for CN. Complications, such as foot ulcers and amputations, provide an understanding of the severe outcome of this condition on patients' quality of life. Management approaches and treatment involving conservative and surgical approaches are reviewed in depth. A multidisciplinary approach to patient care is emphasized, given the complex nature of CN and the comorbidities existing in diabetic individuals. Prognosis and prevention comprise approaches for mitigating the risk of CN in diabetic patients, such as glycemic control, regular foot examinations, and patient education. This thorough review aims to outline the intricate relationship between CN and diabetes, offering an understanding of pathophysiology, clinical complexities, diagnostic nuances, treatment modalities, and prevention strategies.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Pamidronate in diabetic charcot neuroarthropathy: A randomised placebo controlled trial
    Jude, EB
    Page, S
    Donohue, M
    Foster, A
    Edmonds, M
    Mawer, B
    Adams, J
    Selby, P
    Boulton, AJM
    DIABETOLOGIA, 2000, 43 : A16 - A16
  • [32] Dynamic of bone turnover markers in chronic diabetic Charcot neuroarthropathy
    Shepelekevich, AP
    Zabarovskaya, ZV
    Romeiko, DI
    Tolkachev, JV
    BONE, 2005, 36 : S335 - S335
  • [33] Surgical treatment of midfoot Charcot neuroarthropathy with osteomyelitis in patients with diabetes: a systematic review
    Ramanujam, Crystal L.
    Stuto, Alan C.
    Zgonis, Thomas
    JOURNAL OF WOUND CARE, 2020, 29 (06) : S19 - S28
  • [34] Pamidronate in diabetic Charcot neuroarthropathy: A randomised placebo controlled trial
    Jude, E
    Page, S
    Donohoe, M
    Foster, A
    Edmonds, M
    Mawer, B
    Adams, J
    Selby, P
    DIABETES, 2000, 49 : A32 - A33
  • [35] MODERN APPROACHES TO SURGICAL TREATMENT OF CHARCOT NEUROARTHROPATHY (review)
    Pavlyuchenko, S. V.
    Zhdanov, A. I.
    Orlova, I. V.
    TRAVMATOLOGIYA I ORTOPEDIYA ROSSII, 2016, 22 (02): : 114 - 123
  • [36] Diabetic Charcot neuroarthropathy: The diagnosis must be considered in all diabetic neuropathic patients presenting with a hot, swollen foot
    Al-Busaidi, Ibrahim S.
    Mason, Rhett
    Lunt, Helen
    NEW ZEALAND MEDICAL JOURNAL, 2015, 128 (1423) : 77 - 80
  • [37] Charcot Neuroarthropathy of the Knee
    Illgner, Ulrich
    AKTUELLE RHEUMATOLOGIE, 2020, 45 (03) : 232 - 236
  • [38] A Systematic Review of Intramedullary Fixation in Midfoot Charcot Neuroarthropathy
    Wukich, Dane K.
    Liu, George T.
    Johnson, Matthew J.
    Van Pelt, Michael D.
    Raspovic, Katherine M.
    Lalli, Trapper
    Nakonezny, Paul
    JOURNAL OF FOOT & ANKLE SURGERY, 2022, 61 (06): : 1334 - 1340
  • [39] Musgrave-Mitchell-Charcot neuroarthropathy: a review and hypothesis
    Blake, DR
    Shenker, NG
    Mapp, PI
    Haigh, R
    Harris, N
    PAIN REVIEWS, 2002, 9 (01): : 1 - 6
  • [40] Two-year incidence of bacteremia in diabetic foot ulcer patients with and without Charcot Neuroarthropathy
    Ho, TC
    Decuir, A
    Yoo, S
    Sheehan, P
    Harkless, LB
    DIABETES, 2001, 50 : A478 - A478